Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;9(2):949-958.
doi: 10.21037/tau.2020.02.09.

Primary and post-chemotherapy robotic retroperitoneal lymph node dissection for testicular cancer: a review

Shagnik Ray  1 , Phillip M Pierorazio  1 , Mohamad E Allaf  1
Affiliations
Review

Primary and post-chemotherapy robotic retroperitoneal lymph node dissection for testicular cancer: a review

Shagnik Ray et al. Transl Androl Urol. 2020 Apr.

Abstract

Open retroperitoneal lymph node dissection (RPLND) is the gold standard for surgical management of the retroperitoneum in patients with testicular cancer, and is associated with excellent oncologic outcomes and significant morbidity including length of stay. Minimally invasive RPLND, starting with laparoscopic retroperitoneal lymph node dissection in 1992 and now robotic retroperitoneal lymph node dissection in 2006, endeavor to decrease the morbidity of open RPLND while maintaining excellent oncologic outcomes. This review surveys the literature regarding both primary and post-chemotherapy robotic RPLND, emphasizing that while early outcomes are promising, much work needs to be done before widespread use of this technique is implemented.

Keywords: Robotic; post-chemotherapy; retroperitoneal lymph node dissection; testicular cancer.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The series “Robotic-assisted Urologic Surgery” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

References

    1. Motzer RJ, Jonasch E, Agarwal N, et al. Testicular Cancer, Version 2.2015. J Natl Compr Canc Netw 2015;13:772-99. 10.6004/jnccn.2015.0092 - DOI - PubMed
    1. Albers P, Albrecht W, Algaba F, et al. Guidelines on Testicular Cancer: 2015 Update. Eur Urol 2015;68:1054-68. 10.1016/j.eururo.2015.07.044 - DOI - PubMed
    1. Patel HD, Joice GA, Schwen ZR, et al. Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes. World J Urol 2018;36:73-8. 10.1007/s00345-017-2099-0 - DOI - PubMed
    1. Pierorazio PM, Biles MJ. Indications for Surgery in Disseminated Seminoma. Urol Clin North Am 2019;46:399-407. 10.1016/j.ucl.2019.04.005 - DOI - PubMed
    1. Subramanian VS, Nguyen CT, Stephenson AJ, et al. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Urol Oncol 2010;28:504-9. 10.1016/j.urolonc.2008.10.026 - DOI - PubMed